Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-14-007760
Filing Date
2014-11-05
Accepted
2014-11-05 16:34:57
Documents
3
Period of Report
2014-11-05

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT pre14a1114_relmada.htm PRE 14A 528359
2 GRAPHIC img1.jpg GRAPHIC 13544
3 GRAPHIC img2.jpg GRAPHIC 7865
  Complete submission text file 0001213900-14-007760.txt   559212
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: PRE 14A | Act: 34 | File No.: 333-184881 | Film No.: 141197388
SIC: 2834 Pharmaceutical Preparations